Rosetta Genomics Ltd (NASDAQ:ROSG)

3.39
Delayed Data
As of Jun 30
 +0.15 / +4.63%
Today’s Change
2.07
Today|||52-Week Range
5.55
+50.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues103.0K201.0K405.0K1.3M
 
 
 
 
 
Cost of Goods Sold324.0K258.0K411.0K1.0M
 
 
 
 
 
Depreciation And Amortization454.0K274.0K298.0K299.0K
 
 
 
 
 
 
Operating ExpensesGross Income-675.0K-331.0K-304.0K17.0K
 
 
 
 
 
General Expenses8.1M7.9M13.0M14.6M
 
 
 
 
 
Research And Development3.4M1.2M1.7M2.2M
 
 
 
 
 
Total Operating Expenses8.9M8.5M13.8M15.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.8M-8.3M-13.3M-14.5M
 
 
 
 
 
Extraordinary Credit1.6M24.0K55.0K79.0K
 
 
 
 
 
Extraordinary Charge0.00-635.0K0.000.00
 
 
Interest Expense On Debt19.0K1.9M0.00--
 
 
 
Other Expenses-239.0K9.0K-24.0K-157.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.4M-10.7M-13.2M-14.5M
 
 
 
 
 
Income Taxes0.000.000.00-15.0K
 
 
Discontinued Operations-1.4M239.0K273.0K0.00
 
 
 
 
Net Income-8.8M-10.5M-12.9M-14.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS126.9K4.4M9.6M11.2M
 
 
 
 
 
Shares To Calculate EPS Diluted126.9K4.4M9.6M11.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$69.60-$2.35-$1.34-$1.29
 
 
 
 
 
EPS Diluted-$69.60-$2.35-$1.34-$1.29
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account